<DOC>
	<DOCNO>NCT00200824</DOCNO>
	<brief_summary>This study determine effect soy product vitro surrogate cancer marker well bone density marker quality life parameter men woman . This study also determine concentration isoflavones ( naturally occur plant compound act like estrogen body ) prostate tissue remove prostatectomy , well blood .</brief_summary>
	<brief_title>Effects Soy Compounds Breast Cancer , Prostate Cancer , Bone Health</brief_title>
	<detailed_description>In United States , consumption soy product dramatically increase past several year . Foods make soy high isoflavones evidence suggest isoflavones , genistein particular , many beneficial property alleviate menopausal side effect reduce risk osteoporosis , breast cancer , prostate cancer . However , data derive largely study animal cell model ; human trial limit . This study determine effect soy isoflavones quality life cancer bone density marker . While isoflavones purport inhibit proliferation cancer cell , concentration require anti-cancer effect determine much high concentration achieve plasma intake isoflavones . Recent animal study suggest isoflavones may concentrate 10-fold tissue compare blood concentration . If true , high concentration would range found cancer cell line research protective cancer . This study determine whether tissue concentration similar , high , different blood concentration . This study last 5 year comprise three population : men prostate cancer androgen ablation therapy , postmenopausal woman hormone replacement therapy ( HRT ) , postmenopausal woman HRT . Participants randomly assign receive either isoflavone placebo two four week . Participants ' serum serum extract incubate cultured human cell line ( prostate cancer , breast cancer osteoblast ) estrogenic non-estrogenic mechanism action investigate . The human serum data complement parallel study direct addition crystalline isoflavones ( genistein , daidzein equol ) culture human cell line . Participant 's serum urine also test marker bone resorption formation . Quality life issue assess questionnaire .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Inclusion Criteria Scheduled prostatectomy Willing able consume study tablet least 2 week prior surgery Willing accept random assignment Signed informed consent Exclusion Criteria Unwilling avoid soy intake study period Currently take antibiotic</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>isoflavones</keyword>
	<keyword>soy</keyword>
	<keyword>postmenopausal</keyword>
	<keyword>men</keyword>
	<keyword>prostate</keyword>
	<keyword>breast</keyword>
	<keyword>bone</keyword>
</DOC>